Sign Up to like & get recommendations! 0
Published in 2020 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2020.31078
Abstract: This cross-sectional study uses Centers for Medicare and Medicaid Services claims data to investigate associations between influenza season severity and mortality and readmission risks after elective surgical aortic valve replacement (SAVR) and coronary artery bypass… read more here.
Sign Up to like & get recommendations! 0
Published in 2018 at "Catheterization and Cardiovascular Interventions"
DOI: 10.1002/ccd.27362
Abstract: To assess the in‐hospital mortality and complications in female between transcatheter aortic valve replacement (TAVR) and surgical aortic valve replacement (SAVR). read more here.
Sign Up to like & get recommendations! 1
Published in 2018 at "Catheterization and Cardiovascular Interventions"
DOI: 10.1002/ccd.27433
Abstract: Transcatheter aortic valve replacement (TAVR) is an alternative to surgical aortic valve replacement (SAVR) for patients with severe symptomatic aortic stenosis (AS) who are at intermediate and high risk for surgery. Commercial use of TAVR… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Catheterization and Cardiovascular Interventions"
DOI: 10.1002/ccd.28014
Abstract: To explore the impact of post‐procedure delirium on resource utilization following transcatheter and surgical aortic valve replacement (TAVR and SAVR, respectively). read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "Catheterization and Cardiovascular Interventions"
DOI: 10.1002/ccd.29105
Abstract: Stroke is a feared complication of transcatheter aortic valve replacement (TAVR) and surgical aortic valve replacement (SAVR). read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Catheterization and Cardiovascular Interventions"
DOI: 10.1002/ccd.30195
Abstract: In the recommend early surgical intervention for patients with dysfunction, persistent bacteremia, recurrent emboli, relapsing and the wide-spread utilization of transcatheter a retrospective database of TAVR with of (2.21%) surgical aortic valve (SAVR) the PVE… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "ESC Heart Failure"
DOI: 10.1002/ehf2.14053
Abstract: The optimal treatment for severe aortic valve disease complicated with moderate function mitral regurgitation (FMR) remains controversial. Although isolated surgical aortic valve replacement (SAVR) is reasonable, previous studies also show that moderate FMR might deteriorate… read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "International journal of cardiology"
DOI: 10.1016/j.ijcard.2017.03.156
Abstract: OBJECTIVES To determine which procedure, transcatheter aortic valve implantation (TAVI) or surgical aortic valve replacement (SAVR), for severe aortic stenosis (AS) improves follow-up left ventricular (LV) function or hypertrophy more effectively, we performed the first… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Journal of the American College of Cardiology"
DOI: 10.1016/j.jacc.2019.08.869
Abstract: Transcatheter aortic valve replacement (TAVR) for the treatment symptomatic severe aortic stenosis (AS) is indicated in patients with intermediate or higher surgical risk. The latest trials have shown that TAVR and surgical aortic valve replacement… read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "Journal of the American College of Cardiology"
DOI: 10.1016/s0735-1097(17)34606-5
Abstract: Background: Transcatheter Aortic Valve Replacement (TAVR) has been found to be a safe and effective alternative to Surgical Aortic Valve Replacement (SAVR) in patients with a high/intermediate surgical risk. Comparative outcomes of TAVR vs. SAVR… read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "Journal of the American College of Cardiology"
DOI: 10.1016/s0735-1097(17)35353-6
Abstract: Introduction: Surgical aortic valve replacement (SAVR) remains the definitive treatment for many patients with aortic valve disease. We sought to explore the national and regional trends in SAVR after FDA approval of TAVR in 2011.… read more here.